Peak Flemish New Crown Prevention and Control Notes
Release time:
2020-07-15
The Chinese New Year holiday in 2020 was put at risk by the new coronavirus pneumonia. Before, although I heard that someone in Wuhan had pneumonia, I always felt that there was no need to worry about it thousands of miles away. On January 20, the "human-to-human" broke out, and on the morning of January 23, the news of Wuhan's city closure came. It was really a surprise.
It should be said that the group leaders are quite keen on epidemic prevention and control. On January 21, the group company issued two consecutive notices to remind employees not to go to Wuhan without special circumstances and to wear masks to prevent infection. Reduce visits to relatives and friends and avoid going to crowded places. Employees who have recently been to Wuhan and surrounding areas should avoid going out within 14 days after returning home. If they have symptoms of cold and fever, they should go to the hospital for examination in time and take the initiative to explain the situation... and so on. These tips have clear guiding significance for us who are ignorant. At that time, we, who had made various plans for the New Year, canceled the party one after another and hurried to buy masks and disinfectant to take personal protection.
Even so, the severity of the epidemic prevention and control situation is unimaginable-from 0:00 on January 24, Tianjin launched a first-level response to a major public health emergency. The last time was SARS in 2003. That's when we really realized the seriousness of the new coronavirus. At a loss, the group company issued the "Notice on Preventing New Coronavirus Pneumonia (No. 2)" on January 27, which made detailed and comprehensive arrangements for the organization of epidemic prevention and control, preparation of epidemic prevention supplies, daily epidemic prevention measures and implementation. This undoubtedly points out the focus and direction of the epidemic prevention and control work for us.
After receiving the notice, our Flemish company immediately set up an epidemic prevention leading group headed by General Manager Wang Wei, with a detailed division of labor and clear responsibilities. According to the division of labor, I am mainly responsible for the procurement of epidemic prevention supplies. After confirming the number of alcohol and masks available in the company with my colleagues, I called the supplier on the third day of the new year and asked him to leave us all the alcohol and masks on hand, and continue to add orders with the upstream to ensure our long-term epidemic prevention and resumption of production. Because the mercury thermometer is not convenient to use in the unit, I placed an appointment order for a thermometer in Alibaba for the first time. I was afraid of not being insured. I ran three pharmacies in a row, and finally found a thermometer. The price was ridiculously expensive. At the same time, Mr. Wang also contacted friends in the medical field to buy masks and other epidemic prevention materials. I heard that he could buy a thermometer gun, so I safely withdrew the online order. In order to facilitate the spraying of disinfectant in the office area, I went to the supermarket and bought two large watering cans. I have finished everything I can think of, and my nervous and anxious mood has finally settled down a little.
received the notice of the group to extend the holiday. on the one hand, Mr. Wang asked all employees to minimize going out and do a good job in home protection. on the other hand, he arranged me to set up a file from now on to record the temperature of each employee and co-residents, as well as the time and place of return of employees from other places, and to record the detailed travel situation of each employee in the past 14 days from January 31, actively prepare for the prevention and control of the epidemic and the safe resumption of work.
With the passage of time, the development of the epidemic is becoming more and more thrilling. Looking at the rising numbers every day, everyone's heart is full of panic. More and more people in the WeChat working group of the development zone are eagerly asking where to buy masks and where to find disinfectant. Through communication with the supplier, I learned that their additional 2 tons of alcohol had arrived and 20000 medical masks had been delivered, but they could not be received in time due to traffic barriers. I reported this situation to Mr. Wang again. Mr. Wang said that he had found 1000 masks over there, so that there would be enough time to wait for the masks behind the supplier. After straightening out the protective materials, I couldn't help but break out in a cold sweat. If it weren't for the foresight of the group leaders and the advance notice, they immediately put forward specific requirements for us to prepare epidemic prevention materials. I'm afraid I'm like other people. Like ants on a hot pot, I 've hit a wall everywhere without getting anything.
In order to facilitate the communication of epidemic prevention and control information, the Group and pharmaceutical companies have set up epidemic prevention and control groups, on the one hand, to pay attention to and guide the company's epidemic prevention and control work, requiring enterprises and each employee to sign a commitment to epidemic prevention and control, and effectively put epidemic prevention work in place. On the one hand, all employees of the group are required to learn the "Operation Manual for Resuming Trainees", so that every employee is aware of the various work requirements of returning to work and is prepared to fight. While stepping up efforts to educate employees, the Group and pharmaceutical companies have also introduced new coronary pneumonia emergency plans to guide companies around the world to prepare for the resumption of work. At present, the Group has a number of companies have been approved to resume work, we Flanders has also asked employees to learn and master the requirements of the resumption of work, and developed an epidemic prevention and control plan, to the Binhai New Area Development Zone submitted an application for resumption of work. "There are thousands of sails on the side of the sunken boat, and thousands of trees in front of the sick tree." I hope that our application for resumption of work can be approved as soon as possible, and that the Qingfei Liyan products developed in cooperation with medical institutions can be delivered to the hands of doctors and patients as soon as possible, so as to make our contribution to the prevention and control of the epidemic to the maximum extent. (Liu Hairong)
More information
Two Cement Enterprises Prosperous Production and Sales in May
With the gradual easing of the new crown epidemic, all over the project has started, Hubei, Yunnan two provinces cement market continued to improve, Daye peak cement company, Yunnan peak cement company two enterprises have recently shown a good momentum of production and sales. In May, the sales volume of Yunnan Jianfeng cement continued to rise. As of the time of publication, the average daily shipment volume reached more than 7400 tons, and the highest daily shipment volume reached more than 8700 tons, and the production capacity was fully released. Over the past few days, Yunnan Peak Packaging System has made great efforts to overcome the impact of narrow distribution sites and many cement varieties to ensure the completion of delivery tasks with good quality and quantity every day. In order to further balance production and sales and create conditions for the homogenization of cement delivered from the factory, Yunnan peak packaging system puts forward work requirements for relevant posts, emphasizes equipment inspection and process inspection during production, strictly implements safety operation procedures, and maintains safe and efficient operation of the system. Due to the impact of the new crown epidemic, Hubei cement market started late, Wuhan market is the hardest hit area, the current project construction is still not fully started, the volume pressure is greater. For this reason, daye peak departments cooperate closely, increase market development efforts, develop new mixing stations, focus on increasing the bulk share of Xianning, Huanggang and Wuhan markets, seize the opportunity of fine weather, and achieve the goal of rapid output. Internally, on the basis of equipment technical renovation and production capacity improvement, the delivery is effectively guaranteed, and the daily delivery capacity can basically be maintained at 10,000 tons. In May, Daye Peak sold more than 300000 tons of cement, an increase of 20% over the same period last year, with an average daily sales volume of more than 9900 tons, the highest in the current period since Daye Peak was put into production.
2020
07-31
The company's "safe production month" activities are about to start
June 2020 is the 19th national "safe production month", the theme of the activity is "eliminating hidden dangers of accidents and building a strong line of defense". A few days ago, the group company issued a notice to arrange the activities related to the organization of "safe production month" and put forward requirements. According to the group's "safe production month" activity plan, different key thematic activities will be held in the four weeks of June. The first week is the "Publicity and Safety Education Week", which focuses on the use of WeChat groups, electronic screens, publicity boards, banners, slogans and other forms for safety publicity, and organizes the study of national safety regulations, company safety system specifications and accident-free factory creation standards, Organize to watch safety warning education films, learn accident cases, etc., and improve employees' safety awareness by creating a safety atmosphere and organizing learning activities. The focus of the activities in the second week is "looking for potential sources of danger around you". Each unit takes departments and teams as units to investigate and analyze the potential risk factors in the process of daily production, maintenance and operation, find out the hazard sources that have not been included in the scope of risk point control, and report to the safety management department of the unit to form a risk assessment report, put forward solutions or suggestions, and supervise the implementation of rectification and timely eliminate potential safety hazards. The third week is the "on-site safety innovation achievements exhibition week", which focuses on the achievements of each unit in on-site safety management and on-site safety facilities in the past year, which are displayed in the form of pictures and texts through beautiful articles and wechat, so as to learn from each other and promote common progress. The fourth week is the "safety training and drill week", and the group company organizes the standardization of safety production and the elimination of hidden dangers.
2020
07-31
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-31
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-30
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-22
On April 24, Jiang Xiaomeng, chairman of the group company, presided over the 14th meeting of the 10th board of directors of the company, and deliberated and passed 14 related reports and motions such as the 2019 annual board of directors report, the 2019 general manager business report and the 2019 annual report. The general manager's report pointed out that 2019 is the first year of the implementation of the group's new five-year strategic development plan (2019-2023) and the new three-year business plan (2019-2021) for each business sector. the management team has carried out various operation and management work in an orderly manner around the general policy of "innovation and reform, integration and promotion, scientific layout and steady development", and has better completed the business objectives set by the board of directors at the beginning of the year. In the whole year, the company achieved a total operating income of 3.548 billion billion yuan, an increase of 5.51 percent over the same period last year; net profit attributable to shareholders was 0.725 billion billion yuan, with earnings per share reaching 2.11 billion yuan, an increase of 23.14 percent over the same period last year, a record high; total assets at the end of the year were 5.475 billion billion yuan, an increase of 11.71 percent over the same period last year; and net assets attributable to shareholders were 3.789 billion billion yuan, an increase of 19.81 percent. During the reporting period, the company's two main businesses have achieved great development, benefiting from the further promotion of supply-side structural reform, the overall operation of the cement industry in 2019 is stable, and the industry benefits are further improved. During the reporting period, the company made new progress in the construction of cement projects, completed the acquisition, capital increase and name change of Guizhou Mingchuan (Guizhou Huangping Jianfeng Cement Co., Ltd.), and continued to invest in the construction of its new dry cement production line with a daily output of 4500 tons of clinker.
2020
07-31